Literature DB >> 10206119

Species specific detection of Trypanosoma cruzi and Trypanosoma rangeli in vector and mammalian hosts by polymerase chain reaction amplification of kinetoplast minicircle DNA.

G A Vallejo1, F Guhl, E Chiari, A M Macedo.   

Abstract

Several groups have recently developed molecular tests for the detection of Trypanosoma cruzi, the causative agent of Chagas' disease. Polymerase chain reaction (PCR) amplification of kinetoplast minicircle DNA sequences appears to be the most sensitive method. However, the specificity of PCR-based diagnostic methods was challenged when the complete sequence of Trypanosoma rangeli DNA minicircles was discovered. In the present study, we conducted. PCR experiments using the S35/S36 primers in Rhodnius prolixus and Balb/c mice with single and mixed infections of T. cruzi and/or T. rangeli. In single infections, the profile of each trypanosome was easily distinguishable in haemolymph, salivary gland and intestinal tissues and faeces of insect vectors. In mixed infections of anterior intestine (where T. rangeli is more predominant than T. cruzi), the DNA amplification profile of both parasites was observed simultaneously. Conversely, only the T. cruzi profile was observed in rectal ampulla (where T. cruzi is more abundant than T. rangeli). In mice with single infections of T. cruzi or T. rangeli, the profiles of amplified DNA were easily distinguishable in each case. The T. cruzi profile was dominant in most mixed infections, probably due to the fact that T. cruzi minicircles are more abundant and consequently compete more eagerly for annealing with the S35/S36 primers. In cases of mixed infections where T. rangeli was initially more abundant than T. cruzi, the specific T. rangeli 760 bp band was present for 7 days after infection and then this band and others ranging from 300 to 450 bp disappeared and only the typical T. cruzi 330 bp band remained. The S35/S36 primers used in polyacrylamide gel electrophoresis (PAGE) detected T. cruzi specifically, and prevented misdiagnosis due to the presence of T. rangeli. This technique can also be used to identify parasites in different stages of the infection (acute or chronic) in vertebrate hosts and to localize the parasites in the insect vector.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206119     DOI: 10.1016/s0001-706x(98)00085-0

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  35 in total

1.  Limit of detection of PCR/RFLP analysis of cytochrome oxidase II for the identification of genetic groups of Trypanosoma cruzi and Trypanosoma rangeli in biological material from vertebrate hosts.

Authors:  Amanda Regina Nichi Sá; Karen Yuki Kimoto; Mário Steindel; Edmundo Carlos Grisard; Mônica Lúcia Gomes
Journal:  Parasitol Res       Date:  2018-06-01       Impact factor: 2.289

2.  Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methods.

Authors:  Juan David Ramírez; Felipe Guhl; Eufrosina Setsu Umezawa; Carlos A Morillo; Fernando Rosas; Jose A Marin-Neto; Silvia Restrepo
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

3.  Detection of Trypanosoma cruzi and T. rangeli infections from Rhodnius pallescens bugs by loop-mediated isothermal amplification (LAMP).

Authors:  Oriel M M Thekisoe; Carol V Rodriguez; Francisco Rivas; Andrea M Coronel-Servian; Shinya Fukumoto; Chihiro Sugimoto; Shin-Ichiro Kawazu; Noboru Inoue
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  Abundance, natural infection with trypanosomes, and food source of an endemic species of triatomine, Panstrongylus howardi (Neiva 1911), on the Ecuadorian Central Coast.

Authors:  Anita G Villacís; Sofía Ocaña-Mayorga; Mauricio S Lascano; César A Yumiseva; Esteban G Baus; Mario J Grijalva
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

5.  Immunopathologic characterization of naturally acquired Trypanosoma cruzi infection and cardiac sequalae in cynomolgus macaques (Macaca fascicularis).

Authors:  Harshan Pisharath; Chih-Ling Zao; John Kreeger; Susan Portugal; Thomas Kawabe; Tarea Burton; Lisa Tomaeck; Ahmed Shoieb; Brandy Morenko Campbell; Judy Franco
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

6.  Detection of Trypanosoma cruzi infection in naturally infected dogs and cats using serological, parasitological and molecular methods.

Authors:  G F Enriquez; M V Cardinal; M M Orozco; A G Schijman; R E Gürtler
Journal:  Acta Trop       Date:  2013-03-13       Impact factor: 3.112

7.  Trypanosoma rangeli Tejera, 1920, in chronic Chagas' disease patients under ambulatory care at the Evandro Chagas Clinical Research Institute (IPEC-Fiocruz, Brazil).

Authors:  Maria Auxiliadora de Sousa; Tatiana da Silva Fonseca; Barbara Neves Dos Santos; Sheila Medeiros Dos Santos Pereira; Cristina Carvalhal; Alejandro Marcel Hasslocher Moreno
Journal:  Parasitol Res       Date:  2008-06-18       Impact factor: 2.289

8.  Genetically different isolates of Trypanosoma cruzi elicit different infection dynamics in raccoons (Procyon lotor) and Virginia opossums (Didelphis virginiana).

Authors:  Dawn M Roellig; Angela E Ellis; Michael J Yabsley
Journal:  Int J Parasitol       Date:  2009-07-14       Impact factor: 3.981

9.  Detection of Trypanosoma cruzi and Trypanosoma rangeli infection by duplex PCR assay based on telomeric sequences.

Authors:  Miguel Angel Chiurillo; Gladys Crisante; Agustina Rojas; Andreina Peralta; Manuel Dias; Palmira Guevara; Néstor Añez; José Luis Ramírez
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Species-specific markers for the differential diagnosis of Trypanosoma cruzi and Trypanosoma rangeli and polymorphisms detection in Trypanosoma rangeli.

Authors:  Keila Adriana Magalhães Ferreira; Emanuella Francisco Fajardo; Rodrigo P Baptista; Andrea Mara Macedo; Eliane Lages-Silva; Luis Eduardo Ramírez; André Luiz Pedrosa
Journal:  Parasitol Res       Date:  2014-04-12       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.